Spoke Sciences, Inc.

BAINBRIDGE ISLAND, WA · Founded 2021 · Materials · Private

Functional ingredient formulations and delivery technologies for foods, beverages, and cosmetics

Claim this profile

Follows are private to you and power your alerts

Updated · spokesciences.com

Sector
Materials
Headquarters
BAINBRIDGE ISLAND, WA
Founded
2021
Latest Form D
$628K, Apr 2024
Total capital
$4.5M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$4.5M
4 Form D · last Apr 2024
30 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
14 pending · first 2025
Rank in peer group#83 of 369

Capital timeline

2021202220232024FEDERAL ↑EQUITY ↓Cumulative $4.5M1st Form D$720K2nd Form D$222K3rd Form D$2.9M4th Form D$628K
2021202220232024FEDERAL ↑EQUITY ↓Cumulative $4.5M1st Form D$720K4th Form D$628K

Latest events

  • Private capital raisedForm D · SEC · 4th filing$628K
  • Private capital raisedForm D · SEC · 3rd filing$2.9M
  • Private capital raisedForm D · SEC · 2nd filing$222K
  • Private capital raisedForm D · SEC · 1st filing$720K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 369 peers

Line = median

Materials · Material

  • Granted patents#83 · top 22%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Andrea F Leone-BayResearcherDirectorLinked by 1 patent
  • Gregory F WesnerExecutive Officer, DirectorNamed in SEC Form D filings
  • Mark F MitchnickDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 15
Show all 15 patent records
  • Fast-acting Plant-based Medicinal Compounds And Nutritional SupplementsDec 4, 2025 · Application 19299150Pending
  • N-acylated Fatty Amino Acids To Reduce Absorption Variability In Cannabinoid Based CompositionsAug 28, 2025 · Application 19197725Pending
  • N-acylated Fatty Amino Acids To Reduce Absorption Variability In Cannabinoid Based CompositionsMay 20, 2025 · US 12,303,487Granted
  • Particles, Aqueous Dispersions, And Liquid Compositions Having High Lipophilic Component Concentrations And High Lipophilic Component To Surfactant RatiosMay 15, 2025 · Application 18715607Pending
  • Fast-acting Plant-based Medicinal Compounds And Nutritional SupplementsApr 17, 2025 · Application 18990487Pending
  • Fast-acting Plant-based Medicinal Compounds And Nutritional SupplementsAug 8, 2024 · Application 18461125Pending
  • Particles, Aqueous Dispersions, And Compositions Having High Lipophilic Component Concentrations And High Lipophilic Component To Surfactant RatiosAug 8, 2024 · Application 18421851Pending
  • Herbal Compositions With Improved BioavailabilityJan 4, 2024 · Application 18466461Pending
  • Medicinal Compounds And Nutritional SupplementsSep 21, 2023 · Application 17834798Pending
  • Fast-acting Plant-based Medicinal Compounds And Nutritional SupplementsMay 5, 2022 · Application 17572334Pending
  • Particles, Aqueous Dispersions, And Compositions Having High Lipophilic Component Concentrations And High Lipophilic Component To Surfactant RatiosApplication 63624669Pending
  • Formulations Having A Glycoside And A Lipophilic ComponentApplication 63624664Pending
  • Glycoside Combinations In Aqueous Formulations Having A Lipophilic Active ComponentApplication 63593947Pending
  • Particles, Aqueous Dispersions, And Liquid Compositions Having High Lipophilic Component Concentrations And High Lipophilic Component To Surfactant RatiosApplication PCTUS2022051563Pending
  • Particles, Aqueous Dispersions, And Liquid Compositions Having High Lipophilic Component Concentrations And High Lipophilic Component To Surfactant RatiosApplication 63284921Pending

Regulatory activity · Materials

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .